Skip to main content
JAMA Network logoLink to JAMA Network
. 2022 Nov 30;80(2):191. doi: 10.1001/jamapsychiatry.2022.4181

Error in Results

PMCID: PMC9713670  PMID: 36449311

In the Original Investigation titled “Effect of Zuranolone vs Placebo in Postpartum Depression: A Randomized Clinical Trial,”1 published in the September 2021 issue, there was an error in the Results section. The number of patients in the zuranolone and placebo groups who had new antidepressant medication treatment initiatied by investigators were switched and should be 6 and 4, respectively. This article has been corrected online.

Reference

  • 1.Deligiannidis KM, Meltzer-Brody S, Gunduz-Bruce H, et al. Effect of zuranolone vs placebo in postpartum depression: a randomized clinical trial. JAMA Psychiatry. 2021;78(9):951-959. doi: 10.1001/jamapsychiatry.2021.1559 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from JAMA Psychiatry are provided here courtesy of American Medical Association

RESOURCES